Cardiac Failure Simulating Viral Hepatitis

Logan, Robert G.; Mowry, Frank M.; Judge, Richard D.

doi:10.7326/0003-4819-56-5-784

Cited by 37 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only the most severe cases typically manifest hepatic complications, such as jaundice, which may be mistaken for biliary obstruction [11]. In acute heart failure, jaundice and a significant increase in serum aminotransferases may simulate acute viral hepatitis [12,13]. Patients may also experience right upper quadrant discomfort due to straining of the liver capsule and ascites [14,15].…”

Section: Liver In Heart Failurementioning

confidence: 99%

The Liver in Heart Failure: From Biomarkers to Clinical Risk

Aspromonte,

Fumarulo,

Petrucci

et al. 2023

IJMS

View full text Add to dashboard Cite

Heart failure (HF) is a clinical syndrome due to heart dysfunction, but in which other organs are also involved, resulting in a complex multisystemic disease, burdened with high mortality and morbidity. This article focuses on the mutual relationship between the heart and liver in HF patients. Any cause of right heart failure can cause hepatic congestion, with important prognostic significance. We have analyzed the pathophysiology underlying this double interaction. Moreover, we have explored several biomarkers and non-invasive tests (i.e., liver stiffness measurement, LSM) potentially able to provide important support in the management of this complex disease. Cardiac biomarkers have been studied extensively in cardiology as a non-invasive diagnostic and monitoring tool for HF. However, their usefulness in assessing liver congestion in HF patients is still being researched. On the other hand, several prognostic scores based on liver biomarkers in patients with HF have been proposed in recent years, recognizing the important burden that liver involvement has in HF. We also discuss the usefulness of a liver stiffness measurement (LSM), which has been recently proposed as a reliable and non-invasive method for assessing liver congestion in HF patients, with therapeutic and prognostic intentions. Lastly, the relationship between LSM and biomarkers of liver congestion is not clearly defined; more research is necessary to establish the clinical value of biomarkers in assessing liver congestion in HF patients and their relationship with LSM.

show abstract